Tacrolimus sustained-release capsule project
2023-06-06
release unit：华北制药集团新药研究开发有限责任公司
core technology：Chemical pharmaceuticals: preparations
project unit：North China Pharmaceutical Group New Drug Research and Development Co., Ltd
industry field：Other areas
Project description
The total investment of the project is 27.86 million yuan. The project starts and ends from October 2020 to December 2023. The number of project teams is 15. The main business areas are high-end pharmaceutical preparations, core technology, oral sustained-release intention. The country is the United States, and the intention unit is LATITUDePharmaceuticals Inc (LATITUDE Pharmaceuticals) Address California, USA
favorite